EUVIMEDEUVIMED entdecken
Crossref

Quantitative Analysis of Bimiralisib in Dried Blood Spots of Mouse Blood Using a Validated LC‐MS/MS Method: An Application to Pharmacokinetic Study

Ashok Zakkula iD, M Akiful Haque

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Ashok Zakkula und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis School of Pharmacy, Anurag University Medchal-Malkajgiri, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Dried Blood Spot Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bimiralisib, a pan‐PI3K/mTOR inhibitor, has demonstrated antitumor efficacy in preclinical models. In this study, we present a validated LC‐MS/MS method for quantifying bimiralisib from dried blood spots (DBS) in mice. The method was validated in accordance with FDA guidelines. Bimiralisib was extracted from DBS disks using a liquid–liquid extraction technique. Chromatographic separation was achieved on an Atlantis dC18 column (100 × 4.6 mm) using an isocratic mobile phase. The flow rate was set at 0.70 mL/min. Under optimized conditions, the retention times for bimiralisib and the internal standard (IS, Nilotinib) were approximately 1.14 and 1.27 min, respectively, with a total run time of 2.00 min per injection. The monitored MS/MS ion transitions were m / z 412.2 → 141.0 for bimiralisib and 530.4 → 259.0 for the IS. The method employed a broad calibration range (1.00–1434 ng/mL) with a determination coefficient ( r 2 ) of 0.996. All validation parameters met the required acceptance criteria, and hematocrit levels had no impact on bimiralisib concentrations in DBS. The validated method was utilized to determine intravenous and oral pharmacokinetic parameters by quantifying bimiralisib in mouse blood, with results correlated to pharmacokinetic data from mice plasma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryDried Blood Spot TestingAnimalsMiceChromatography, LiquidReproducibility of ResultsLinear ModelsLimit of DetectionMaleLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DBSLC‐MS/MSbimiralisibmethod validationmouse bloodpharmacokinetics

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis School of Pharmacy, Anurag University Medchal-Malkajgiri, Hyderabad, Telangana, India.

ORCID-Profile: Ashok Zakkula

Zitieren

APA

Zakkula, A., & Haque, M. A. (2025). Quantitative Analysis of Bimiralisib in Dried Blood Spots of Mouse Blood Using a Validated LC‐MS/MS Method: An Application to Pharmacokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70087

Vancouver

Zakkula A, Haque MA. Quantitative Analysis of Bimiralisib in Dried Blood Spots of Mouse Blood Using a Validated LC‐MS/MS Method: An Application to Pharmacokinetic Study. Biomedical Chromatography. 2025. doi:10.1002/bmc.70087

BibTeX
@article{Zakkula2025,
  author = {Zakkula, Ashok and Haque, M Akiful},
  title = {Quantitative Analysis of Bimiralisib in Dried Blood Spots of Mouse Blood Using a Validated LC‐MS/MS Method: An Application to Pharmacokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70087}
}
Kostenlos starten →